Modulators of alpha-1 antitrypsin

30-01-2024 дата публикации

Номер:

US0011884672B2

Автор: Upul Keerthi Bandarage, Cavan McKeon Bligh, Diane BOUCHER, Michael John Boyd, Michael Aaron BRODNEY, Michael Philip Clark, Veronique DAMAGNEZ, Lev Tyler Dewey Fanning, Robert Francis FIMOGNARI, Gabrielle Simone FLEMING, Kevin James GAGNON, Pedro Manuel GARCIA BARRANTES, Robert Daniel GIACOMETTI, Simon Giroux, Ronald Lee Grey, Jr., Samantha GUIDO, Amy Beth HALL, Sarah Carol HOOD, Dennis James Hurley, Mac Arthur Johnson, JR., PETER JONES, Sarathy KESAVAN, Mei-Hsiu LAI, Siying LIU, Adam Looker, Brad MAXWELL, John Patrick Maxwell, Ales Medek, Philippe Marcel Nuhant, Kirk Alan OVERHOFF, Setu RODAY, Stefanie Roeper, Steven M. Ronkin, Rupa SAWANT, YI SHI, Muna Shrestha, Marisa SPOSATO, Kathy Stavropoulos, Rebecca Jane SWETT, Timothy Lewis TAPLEY, QING TANG, Stephen THOMSON, Jinwang Xu, Mariam ZAKY, Kevin Michael Cottrell

Принадлежит: Vertex Pharmaceuticals Incorporated

Контакты:

Номер заявки: 56-12-1593

Дата заявки: 13-05-2020

CPC - классификация

A A6 A61 A61K A61K3 A61K31 A61K31/A61K31/4 A61K31/41 A61K31/416 A61K31/4162 A61K31/417 A61K31/4178 A61K31/419 A61K31/4196 A61K31/42 A61K31/422 A61K31/429 A61K31/43 A61K31/433 A61K31/437 A61K31/44 A61K31/443 A61K31/4439 A61K31/45 A61K31/454 A61K31/49 A61K31/496 A61K31/497 A61K31/498 A61K31/4985 A61K31/5 A61K31/50 A61K31/506 A61K31/53 A61K31/537 A61K31/5377 A61K31/6 A61K31/67 A61K31/675 A61K31/69 A61K31/7 A61K31/70 A61K31/705 A61K31/7056 A61K9 A61K9/A61K9/1 A61K9/16 A61K9/163 A61K9/1635 A61K9/165 A61K9/1652 A61P A61P1 A61P1/A61P1/1 A61P1/16 A61P11 A61P11/A61P11/0 A61P11/00 A61P17 A61P17/A61P17/0 A61P17/00 C C0 C07 C07B C07B2 C07B22 C07B220 C07B2200 C07B2200/C07B2200/0 C07B2200/07 C07B2200/1 C07B2200/13 C07D C07D2 C07D23 C07D231 C07D231/C07D231/5 C07D231/56 C07D4 C07D40 C07D405 C07D405/C07D405/0 C07D405/06 C07D47 C07D471 C07D471/C07D471/1 C07D471/14 C07D48 C07D487 C07D487/C07D487/0 C07D487/04 C07D487/1 C07D487/14 C07D49 C07D491 C07D491/C07D491/1 C07D491/18 C07D498 C07D498/C07D498/1 C07D498/18 C07D498/2 C07D498/22 C07D5 C07D51 C07D513 C07D513/C07D513/0 C07D513/04 C07D519 C07D519/C07D519/0 C07D519/00 C07F C07F5 C07F5/C07F5/0 C07F5/02 C07F5/025 C07F9 C07F9/C07F9/6 C07F9/65 C07F9/656 C07F9/6561 C07H C07H1 C07H13 C07H13/C07H13/0 C07H13/08 C07H15 C07H15/C07H15/2 C07H15/26 C07H19 C07H19/C07H19/2 C07H19/23

IPC - классификация

A A6 A61 A61K A61K3 A61K31 A61K31/A61K31/4 A61K31/41 A61K31/416 A61K31/4162 A61K9 A61K9/A61K9/1 A61K9/16 A61P A61P3 A61P35 A61P35/A61P35/0 A61P35/00 A61P4 A61P43 A61P43/A61P43/0 A61P43/00 C C0 C07 C07D C07D4 C07D48 C07D487 C07D487/C07D487/0 C07D487/04 C07D487/1 C07D487/14 C07D49 C07D491 C07D491/C07D491/1 C07D491/18 C07D5 C07D51 C07D513 C07D513/C07D513/0 C07D513/04 C07D519 C07D519/C07D519/0 C07D519/00 C07F C07F9 C07F9/C07F9/6 C07F9/65 C07F9/656 C07F9/6561 C07H C07H1 C07H15 C07H15/C07H15/2 C07H15/26

Цитирование НПИ

Akhapkina, V.I. et al. (2012) “Fundamental bases of modulatory concept and classification of modulatory drugs”, Russian Medical Journal, 19: 933-951.
Aldonyte Ruta et al: “Analysis of systemic biomarkers in COPD patients”, COPD: Journal of Chronic Obstructive Pulmonary Disease, Informa Healthcare, US, vol. 1, No. 2, Jan. 1, 2004 (Jan. 1, 2004), pp. 155-164
American Thoracic Society & European Respiratory Society (2003) “American Thoracic Society/European Respiratory Society Statement: Standards forthe Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency,” Am J Respir Crit Care Med., 168:818-900.
Balle, T. et al. (2003) “Synthesis and Structure-Affinity Relationship Investigations of 5-Aminomethyl and 5-Carbamoyl Analogues of the Antipsychotic Senindole. A New Class of Selective α1Adrenoceptor Antagonists,” Bioorg. Med. Chem., 11:1065-1078.
Bergin, D.A. et al. (2014) “The circulating proteinase inhibitor alpha-1 antitrypsin regulates neutrophil degranulation and autoimmunity,” Sci Transl Med., 6(217):217ra1 (70 pages).
Chou, T.-C. (2010) “Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method”, Cancer Res; 70(2):440-446.
Dafforn, T. R. et al: “A kinetic mechanism for the polymerization of alpha1-antitrypsin”, The Journal of Biological Chemistry, vol. 274, No. 4, Apr. 2, 1999 (Apr. 2, 1999), pp. 9548-9555
Donawade, D.S. et al. (Apr. 2007) “Synthesis and antimicrobial activity of novel linearly fused 5-substituted-7-acetyl-2,6-dimethyloxazolo[4,5-f] indoles,” Indian Journal of Chemistry, 46B:690-693.
Eggenschwiler, R. et al: “Sustained Knockdown of a Disease Causing Gene in Patient-Specific Induced Pluripotent Stem Cells Using Lentiviral Vector-Based Gene Therapy”, Stem Cells Translational Medicine, vol. 2, No. 9, Sep. 1, 2013 (Sep. 1, 2013), pp. 641-654
Ferrarotti, I. et al: “Quantification of circulating alpha-1-antitrypsin polymers in dried blood spots”, Molecular Pathology and Funct. Genomics, vol. 56, Sep. 7, 2020 (Sep. 7, 2020), p. 326.
Forbes, I.T. et al. (1996) “Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT2C/2BReceptor Antagonists,” J. Med. Chem., 39:4966-4977.
Fregonese, F. & J. Stolk (2008) “Hereditary alpha-1-antitrypsin deficiency and its clinical consequences,” Orphanet J. Rare Dis., 3:16 (9 pages).
Gadaginamath, G.S. et al. (2000) “Chemoselective Reaction of 3,6-Diacetylindole Towards Hydroxylamine: Synthesis and Antimicrobial Activity of Novel Isoxazolo[4,5-f]indole Derivatives,” Rev. Roum. Chim., 45(10):929-933.
Geraghty, P. et al. (Dec. 2014), “α1-Antitrypsin Activates Protein Phosphatase 2A to Counter Lung Inflammatory Responses,” Am J Respir Crit Care Med, 190(11):1229-1242.
Ghorai, J. et al. (2016) “Cobalt(III)-Catalyzed Intramolecular Cross-Dehydrogenative C—H/X-H Coupling: Efficient Synthesis of Indoles and Benzofurans,” Chem. Eur. J., 22:16042-16046.
Ghorai, J. et al. (2018) “Divergent Functionalization of N-Alkyl-Z-alkenylanilines: Efficient Synthesis of Substituted Indoles and Quinolines,” Chem. Asian J., 13(17):2499-2504.
Gosai, S. et al. (Nov. 2010) “Automated High-Content Live Animal Drug Screening Using C. elegans Expressing the Aggregation Prone Serpin αI-antitrypsin Z,” PLoS One, 5(11):e15460 (16 pages).
Grant & Hackh's Chemical Dictionary (5th ed. 1987), at p. 148.
Harkevich, D.A. (2010) Pharmacology/Textbook, 10th edition, pp. 72-82.
International Search Report and Written Opinion for International Application No. PCT/US2020/032832, dated Oct. 27, 2020 (17 pages).
International Search Report and Written Opinion for International Application No. PCT/US2020/053777, dated Mar. 4, 2021 (11 pages).
International Search Report and Written Opinion for International Application No. PCT/US2021/015614, dated Apr. 29, 2021 (9 pages).
International Search Report and Written Opinion for International Application No. PCT/US2021/025597, dated Jun. 16, 2021 (13 pages).
International Search Report and Written Opinion for International Application No. PCT/US2021/025616, dated Jun. 14, 2021 (12 pages).
International Search Report and Written Opinion for International Application No. PCT/US2021/025623, dated Jun. 14, 2021 (18 pages).
Jiang, H. et al. (2016) “Multiple Roles of the Pyrimidyl Group in the Rhodium-Catalyzed Regioselective Synthesis and Functionalization of Indole-3-carboxylic Acid Esters,” Advanced Synthesis & Catalysis, 358:188-194.
Kamat, A.G. et al. (Mar. 1994), “Synthesis and Antimicrobial Activity of Furoindole Derivatives,” Indian J. Chem. Sect. B, 33B(3):255-259.
Kummerer, K. (2010) “Pharmaceuticals in the environment”, Annual Review of Environment and Resources, 35:57-75.
Kuznetsova, G.A. (2005) “Methodological instructions”, Irkutsk State University, Department of General Physics, pp. 2-3.
Laffranchi, M. et al: “Heteropolymerization of-1-antitrypsin mutants in cell models mimicking heterozygosity”, Human Molecular Genetics, vol. 27, No. 10, Mar. 10, 2018 (Mar. 10, 2018), pp. 1785-1793
Maity, S. et al. (Sep. 2012) “A Visible-Light-Mediated Oxidative C—N Bond Formation/Aromatization Cascade: A New Photocatalytic Preparation of N-Arylindoles,” Angew Chem Int Ed Engl., 51(38):9562-9566. NIH Public Access Author Manuscript; available in PMC Sep. 17, 2013 (11 pages).
Mali, R.S. et al. (1994) “Useful Syntheses of Pyrano- and Pyridoindoles,” Organic Preparations and Procedures International: The New Journal for Organic Synthesis, 26(5):573-577.
Mashovsky (2001) M.D. Drugs, 14th edition, Moscow, 1:11.
Meti, P. et al. (2017) “Regioselective synthesis of dipyrrolopyrazine (DPP) derivatives via metal free and metal catalyzed amination and investigation of their optical and thermal properties,” RSC Adv., 7:18120-18131.
Ogushi, F. et al. (1987) “Z-type α1-antitrypsin is less competent than M1-type α1-antitrypsin as an inhibitor of neutrophil elastase,” J Clin Invest, 80(5):1366-1374.
Piitulainen, E. & H.A. Tanash (2015), “The Clinical Profile of Subjects Included in the Swedish National Register on Individuals with Severe Alpha 1-Antitrypsin deficiency,” COPD, 12(S1):36-41.
Saccarello, M.L. et al. (Sep. 1979) “A New Synthesis of 1-Alkyl-3-aminoindoles,” Synthesis, 1979(9):727-729.
Song, X. et al. (2018) “Regioselective Synthesis of 2-Alkenylindoles and 2-Alkenylindole-3-carboxylates through the Cascade Reactions of N-Nitrosoanilines with Propargyl Alcohols,” J. Org. Chem., 83:8509-8521.
Tanash, H.A. et al. (2016) “Cause-specific mortality in individuals with severe alpha 1-antitrypsin deficiency in comparison with the general population in Sweden,” International Journal of COPD, 2016(11):1663-1669.
Tidwell et al. Diarylamidine Derivatives with One or Both of the Aryl Moieties Consisting of an Indole or Indole-like Ring. Inhibitors of Arginine-Specific Esteroproteases. Journal of Medicinal Chemistry, 1978, vol. 21, No. 7, p. 613-623. (Year: 1978).
U.S. Appl. No. 17/060,945, filed Oct. 1, 2020, by Bozic et al.
U.S. Appl. No. 18/018,245, filed Jan. 26, 2023, by Bligh et al.
U.S. Appl. No. 18/036,491, filed May 11, 2023, by Penney et al.
U.S. Appl. No. 18/037,121, filed May 16, 2023, by Shi et al.
Wen, W. et al. (2014) “Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354,” Bioorg. Med. Chem. Lett., http://dx.doi.org/10.1016/j.bmcl.2014.08.021.

Получить PDF